## BACKGROUND. A variety of hormones have demonstrated effects on prostatic tissue growth dynamics. Our goal was to define the effect of dihydrotestosterone (DHT), epidermal growth factor (EGF), and prolactin (PRL) on prostate cellular proliferation. METHODS. Thirty benign human prostatic hyperpla
Regional distribution of epidermal growth factor, testosterone and dihydrotestosterone in benign prostatic hyperplasia tissue
โ Scribed by Sciarra, F. ;Monti, S. ;Adamo, M. V. ;Palma, E. ;Toscano, V. ;d'Eramo, G. ;di Silverio, F.
- Publisher
- Springer
- Year
- 1995
- Tongue
- English
- Weight
- 381 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0300-5623
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Background: The n-hexane lipido-sterol extract of serenoa repens (lsesr, permixon, pierre fabre medicament, castres, france), a phytotherapeutic agent used in the treatment of benign prostatic hyperplasia (bph), has a multisite mechanism of action including inhibition of types 1 and 2 5alpha-red
## Background: Regional variations in stromal-epithelial interactions, mediated through soluble growth factors, may be responsible for differences in epithelial growth and death observed between regions of the rat prostatic ductal system. since transforming growth factor-beta 1 (tgf-beta 1) can ind